| Description | HDAC-IN-31 is a selective, potent, orally active HDAC inhibitor that acts on HDAC1 (IC50: 84.90 nM), HDAC2 (IC50: 168.0 nM), HDAC3 (IC50: 442.7 nM), HDAC8 (IC50>10000 nM). HDAC-IN-31 has good anti-tumour effects. HDAC-IN-31 has shown potential research value in diffuse large B-cell lymphoma. |
| molecular weight | 412.48 |
| Molecular formula | C25H24N4O2 |
| CAS | 1916505-13-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |